Fanconi Anemia: A Patient Guide
At a Glance
Fanconi anemia is a rare inherited DNA-repair disorder that can affect blood production, growth, and several organs while increasing cancer risk. A stem cell transplant can treat bone marrow failure, but lifelong, multidisciplinary screening remains essential.
Fanconi anemia (FA) is a rare genetic condition that changes how your child’s body handles the “wear and tear” of everyday life at the most fundamental level. In a typical cell, the body uses a specialized set of proteins to find and fix damage to its DNA, ensuring that cells can divide and grow correctly. In a child with Fanconi anemia, the instructions for this repair process are missing or altered, leaving their cells vulnerable to damage that most people’s bodies would easily correct [1]. Because DNA is the blueprint for every part of the body, this repair defect can affect many different systems at once. The manifestations often include congenital differences present at birth, challenges with growth, endocrine and fertility issues, kidney and hearing findings, and changes to how the blood is produced [2].
The management of this condition is often described as addressing a complex set of challenges that can unfold in varied ways over a person’s life, rather than following a single fixed sequence. One major challenge involves the bone marrow—the body’s blood-forming factory—which often struggles to keep up with the demand for new red cells, white cells, and platelets. As the factory slows down, it becomes harder for the body to carry oxygen, fight off common germs, or stop simple bleeding. Another critical challenge is a significantly higher risk of developing certain cancers, particularly squamous cell carcinomas of the head and neck, as the accumulation of unrepaired DNA damage over many years can cause healthy cells to become malignant [3].
Treating Fanconi anemia requires a specialized approach that recognizes these unique vulnerabilities. A stem cell transplant is a powerful, life-saving tool that can replace a failing bone marrow factory with healthy donor cells, treating the blood-related aspects of the disease and reducing the risk of leukemia. However, it is vital to understand that the transplant only treats the blood-forming system; the DNA repair defect remains present in the rest of the body’s tissues, such as the skin and the lining of the mouth and throat. This means that even after a successful transplant, the risk for solid tumors persists, and the transplant process itself can even increase this long-term risk [4].
Because of this lifelong vulnerability, the cornerstone of care for Fanconi anemia is proactive, multidisciplinary surveillance. This means working with a dedicated team of specialists who monitor not only the blood but also growth, hearing, kidney function, and oral health. By catching changes at their earliest and most treatable stages, this “watchful” approach allows families to move from a place of reaction to one of empowerment. While the diagnosis is serious, the goal of modern care is to manage these risks so effectively that children with Fanconi anemia can grow, learn, and thrive alongside their peers [5].
Month 1 Checklist: What to Do Next
- Confirm Testing: Ensure testing was done at an FA-experienced center.
- Establish Baseline Bloodwork: Set up Complete Blood Count (CBC) and marrow follow-up with a specialist.
- Schedule Organ Baselines: Obtain initial hearing, kidney, and developmental assessments.
- Make an Emergency Plan: Create a written fever and bleeding response plan with your hematologist.
- Arrange Genetic Counseling: Discuss sibling testing and, if relevant, HLA typing for future transplant planning.
In this guide
6 chapters
Understanding Fanconi Anemia: An Overview
Learn how Fanconi anemia affects DNA repair, blood cells, and cancer risk, plus physical signs, chromosome-breakage testing, inheritance, and specialist care.
The Diagnostic Journey: Confirming Fanconi Anemia
Learn how Fanconi anemia is confirmed through DEB or MMC chromosome breakage tests, skin fibroblast testing, and genetic sequencing, with copy number testing.
Monitoring the Factory: Bone Marrow and Blood Health
Learn how Fanconi anemia affects bone marrow and blood, including pancytopenia, CBCs, marrow tests, clonal changes, MDS, AML, and transplant timing decisions.
Treating the Blood: Stem Cell Transplant and Androgens
Learn how Fanconi anemia is treated with stem cell transplant or androgens, including donor choices, side effects, monitoring, and gene therapy trials.
Long-Term Health: Solid Tumor Risk and Prevention
Learn how Fanconi anemia raises solid tumor risk and how screening, HPV vaccination, dental care, and prompt lesion checks support lifelong cancer prevention.
Daily Management, Multidisciplinary Care, and Emergencies
Learn how to manage Fanconi anemia at home, coordinate specialist care, monitor transfusion risks, and respond safely to fever, bleeding, and other emergencies.
Common questions in this guide
What is Fanconi anemia, and how can it affect a child?
Why do children with Fanconi anemia need regular blood and marrow checks?
Can a stem cell transplant cure Fanconi anemia?
What should lifelong screening for Fanconi anemia include?
Does cancer risk continue after a stem cell transplant for Fanconi anemia?
What should families ask about FANC gene testing and sibling testing?
How should we prepare for a fever or bleeding episode?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which specific FANC gene mutation does our child have, and what does that mean for their individual prognosis?
- 2.How do you coordinate communication between all the different specialists (hematology, ENT, endocrinology) on our care team?
- 3.What is the long-term plan for transitioning our child from pediatric to adult specialized care?
- 4.How often should we meet to review the surveillance plan as our child reaches different developmental milestones?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (5)
- 1
Research progress of the Fanconi anemia pathway and premature ovarian insufficiency†.
Zhao J, Zhang Y, Li W, et al.
Biology of reproduction 2023; (109(5)):570-585 doi:10.1093/biolre/ioad110.
PMID: 37669135 - 2
How I treat MDS and AML in Fanconi anemia.
Peffault de Latour R, Soulier J
Blood 2016; (127(24)):2971-9 doi:10.1182/blood-2016-01-583625.
PMID: 27020090 - 3
Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up.
Alter BP, Giri N, Savage SA, Rosenberg PS
Haematologica 2018; (103(1)):30-39 doi:10.3324/haematol.2017.178111.
PMID: 29051281 - 4
Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis.
Yabe M, Morio T, Tabuchi K, et al.
International journal of hematology 2021; (113(1)):134-144 doi:10.1007/s12185-020-02991-x.
PMID: 32949371 - 5
Monitoring and treatment of MDS in genetically susceptible persons.
Davies SM
Hematology. American Society of Hematology. Education Program 2019; (2019(1)):105-109 doi:10.1182/hematology.2019000020.
PMID: 31808891
This Fanconi anemia guide is for informational purposes only and does not constitute medical advice. Your child’s hematology and genetics team should tailor testing, transplant decisions, and lifelong screening to their needs.
Get notified when new evidence is published on Fanconi anemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.